Cytomegalovirus cultured from different major leukocyte subpopulations: Association with clinical features in CMV immunoglobulin G-positive renal allograft recipients
P. Schafer et al., Cytomegalovirus cultured from different major leukocyte subpopulations: Association with clinical features in CMV immunoglobulin G-positive renal allograft recipients, J MED VIROL, 61(4), 2000, pp. 488-496
Cytomegalovirus (CMV) cultured from peripheral blood mononuclear cells (PBM
Cs) was shown to be associated more closely with clinical manifestations th
an infectious CMV in polymorphonuclear leukocytes (PMNLs) of renal allograf
t recipients with secondary CMV infection. Shell vial culture was carried o
ut with ficoll-purified PBMCs and PMNLs of 71 CMV IgG-positive patients aft
er kidney transplantation. Thirty-six patients experienced active CMV infec
tions. Of these, 17 developed clinical symptoms. The diagnostic value of PM
NLs and PBMCs viremia was determined in comparison to pp65 antigenemia, leu
koDNAemia, plasma DNAemia, and detection of cytomegalic endothelial cells.
In both PMNLs and PBMCs (with or without detectable endothelial cells), fre
quencies and levels of viremia were significantly higher among symptomatic
patients. Regarding the occurrence of clinical CMV manifestations, the sens
itivity of culture from PMNLs and from PBMCs fractions was 100%. Viremia in
PBMCs, however, was far more specific (94%) than in PMNLs (74%). Cutoff va
lues established previously for pp65 antigenemia and leukoDNAemia, standard
markers in the laboratory, had similar specificity (96% each) to PBMCs vir
emia, but were less sensitive (88% each). Plasma DNAemia was both less sens
itive (82%) and less specific (69%) than PBMCs viremia. Detection of endoth
elemia showed maximal specificity (100%), but inferior sensitivity (47%). A
ll patients had PBMCs viremia before the onset of symptoms. In conclusion,
infectious CMV present in PBMCs may prove to be a determinant of clinical C
MV manifestations in seropositive immunocompromised individuals. Factors in
volved in PBMCs tropism may help to understand the pathogenetic mechanisms
of CMV dissemination in this group of patients. J. Med. Virol. 61:488-496,
2000. (C) 2000 Wiley-Liss, Inc.